NCT00055341View on ClinicalTrials.gov

Treatment of Hepatitis C in Hemophilic Patients With HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

June 30, 2005

Conditions
HIV InfectionsHepatitis CHemophilia
Interventions
DRUG

Peginterferon alfa-2a

DRUG

Ribavirin

Trial Locations (1)

45267

University of Cincinnati, Cincinnati

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00055341 - Treatment of Hepatitis C in Hemophilic Patients With HIV | Biotech Hunter | Biotech Hunter